These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29414277)

  • 21. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
    Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
    Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.
    Evens AM; Roy R; Sterrenberg D; Moll MZ; Chadburn A; Gordon LI
    Curr Oncol Rep; 2010 Nov; 12(6):383-94. PubMed ID: 20963522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM; Parsonage G; Fox CP; Lee SP
    Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttransplantation lymphoproliferative disorders.
    Andreone P; Gramenzi A; Lorenzini S; Biselli M; Cursaro C; Pileri S; Bernardi M
    Arch Intern Med; 2003 Sep; 163(17):1997-2004. PubMed ID: 14504111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoproliferation in children after liver transplantation.
    Smets F; Sokal EM
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):499-505. PubMed ID: 12050573
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH; Morrison VA
    Expert Rev Hematol; 2010 Feb; 3(1):35-44. PubMed ID: 21082932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New approaches to posttransplant lymphoproliferative disorder (PTLD).
    Porcu P
    Clin Adv Hematol Oncol; 2005 Jan; 3(1):24-6. PubMed ID: 16166963
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent advances on diagnosis and therapy of lymphoproliferative disorders after allo-HSCT].
    Gu B; Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):538-42. PubMed ID: 24763039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients.
    Allen U; Preiksaitis J;
    Am J Transplant; 2009 Dec; 9 Suppl 4():S87-96. PubMed ID: 20070701
    [No Abstract]   [Full Text] [Related]  

  • 31. [The importance of more research on post-transplant lymphoproliferative disorders in China].
    Liu QF
    Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):977-8. PubMed ID: 18478909
    [No Abstract]   [Full Text] [Related]  

  • 32. [Post-transplantation lymphoproliferative disorder in childhood].
    Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
    Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
    Green M; Webber SA
    Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives.
    Compagno F; Basso S; Panigari A; Bagnarino J; Stoppini L; Maiello A; Mina T; Zelini P; Perotti C; Baldanti F; Zecca M; Comoli P
    Front Immunol; 2020; 11():567020. PubMed ID: 33042147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
    Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A
    Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.
    Glotz D; Chapman JR; Dharnidharka VR; Hanto DW; Castro MC; Hirsch HH; Leblond V; Mehta AK; Moulin B; Pagliuca A; Pascual J; Rickinson AB; Russo FP; Trappe RU; Webster AC; Zuckermann AO; Gross TG
    Transplantation; 2012 Oct; 94(8):784-93. PubMed ID: 22992767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
    Milpied N; Coste-Burel M; Accard F; Moreau A; Moreau P; Garand R; Harousseau JL
    Bone Marrow Transplant; 1999 Mar; 23(6):629-30. PubMed ID: 10217196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr Virus-related Posttransplant Lymphoproliferative Disorder in Children: A Single-institution Experience.
    Jaing TH; Wu CT; Chen SH; Wen YC; Chang TY; Chuang WY
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e133-6. PubMed ID: 26886374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].
    Bay JO; Peffault de Latour R; Bruno B; Coiteux V; Guillaume T; Hicheri Y; Paillard C; Suarez F; Turlure P; Alain S; Bulabois CE; Socié G; Bauters F; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):152-4. PubMed ID: 24011961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransplant lymphoproliferative disorder.
    Everly MJ; Bloom RD; Tsai DE; Trofe J
    Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.